SCHEDULE 13D/A: KKR Affiliate Secures Board Seat at Henry Schein Inc., Amends Voting Agreement

KKR-affiliated entities have reported a 9.9% beneficial ownership stake in Henry Schein Inc., leading to the appointment of Max Lin to the board and the removal of a prior voting commitment.

Summary

• KKR-affiliated entities, including KKR Hawaii Aggregator L.P. and MH Sub I, LLC, collectively beneficially own 12,016,714 shares of Henry Schein Inc. common stock.
• This represents approximately 9.9% of the 121,719,546 outstanding shares as of April 28, 2025.
• Max Lin, an employee of Kohlberg Kravis Roberts & Co. L.P., was appointed to Henry Schein Inc.'s Board of Directors as a designee of KKR Hawaii Aggregator L.P., effective May 2, 2025.
• As a director, Max Lin may influence the corporate activities of Henry Schein Inc., including potential strategic transactions.
• A Letter Agreement was entered into on May 2, 2025, between Henry Schein Inc. and KKR Hawaii Aggregator L.P. to remove the investor's voting commitment previously outlined in the Partnership Agreement.

Sentiment

Score: 7

Explanation: The filing indicates a significant, strategic investment by KKR, a major private equity firm, in Henry Schein Inc., including board representation. This suggests confidence in the company's future and potential for strategic initiatives, which is generally positive for the issuer. The removal of the voting commitment also provides KKR with more flexibility.

Positives

• KKR's significant 9.9% stake indicates a strong investment and potential long-term interest in Henry Schein Inc.
• The appointment of Max Lin, a KKR employee, to the board provides KKR with direct influence over the company's strategic direction and corporate activities.
• The removal of the voting commitment via the Letter Agreement could provide KKR with greater flexibility in its voting decisions regarding its stake.

Risks

• The appointment of a KKR designee to the board means KKR may exert significant influence over Henry Schein Inc.'s corporate activities, which could align with KKR's investment objectives rather than solely the interests of all shareholders.

Future Outlook

The document does not contain explicit forward-looking statements or guidance from Henry Schein Inc. It primarily details KKR's current ownership stake and board representation.

Industry Context

KKR's investment in Henry Schein Inc., a major distributor of healthcare products and services, reflects continued private equity interest in the healthcare sector, particularly in established market leaders with strong distribution networks. This move could signal KKR's intent to influence strategic direction within the dental and medical supply industry.

Comparison to Industry Standards

• This filing is an ownership disclosure and board appointment, not a financial performance report, so direct comparisons to industry financial benchmarks or specific comparable companies' results are not applicable.
• KKR's 9.9% stake is a significant minority position, typical for activist or strategic investments by large private equity firms seeking influence without outright control.

Management Changes

Corporate Governance

Related Party Transactions

• The Letter Agreement entered into on May 2, 2025, between Henry Schein Inc. and KKR Hawaii Aggregator L.P. to remove the investor's voting commitment is a related party transaction.

Stakeholder Impact

• Shareholders: KKR's significant stake and board representation could lead to strategic changes aimed at enhancing shareholder value, but also means a large block of shares is controlled by a single entity with specific investment goals.
• Management: The presence of a KKR-appointed director may influence management's strategic decisions and operational focus.

Next Steps

• Max Lin, as a director, will participate in Henry Schein Inc.'s board activities and may influence corporate decisions.
• The Letter Agreement removing the voting commitment will govern future voting arrangements between Henry Schein Inc. and KKR Hawaii Aggregator L.P.

Key Dates

Recommendation

Keywords

Henry Schein Inc., KKR, Kohlberg Kravis Roberts, Schedule 13D, beneficial ownership, board appointment, corporate governance, healthcare distribution, dental supplies, medical supplies, private equity investment